Skip to main content
Log in

Localization of gelatinolytic activity can be detected in Breast Cancer tissues by filmin situ zymography

  • Original Article
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Background

Extracellular matrix-degrading proteinases secreted by malignant tumor cells have been thought to play an essential role in the processes of invasion and metastasis. However, existence and localization of gelatinase activity in breast cancer tissues have not been clarified.

Methods

We developed a novel film for highly reproducible detection and the localization of gelatinolytic activity. This film has a gelatin layer with a constant thickness 7 μm, and adequate crosslinking to control the speed of degradation by proteases. Cryosections of several breast cancer tissues were put on this gelatin film and incubated for 16 hrs at 37°C. After staining with ponceau 3R dye, the digested area was evaluated under light microscopy.

Results

Digestion of gelatin was detected in more than 90% of breast cancer specimens, although it varied in degree and area for each case. In most cases, the gelatinolytic activity was located within cancer nests, and was not detected in stromal cells surrounding cancer cells. The gelatinolytic activity was inhibited by 1,10-phenanthroline, an inhibitor of matrix metalloproteinases (MMPs).

Conclusions

In this study, the localization of net MMP activity was confirmed in breast cancer nest using filmin situ zymography. Detailed analysis on the relationship between the strength or distribution of MMP activity and malignancy are anticipated in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

MMP:

Matrix metalloproteinase

MT-MMP:

Membrane type matrix metalloproteinase

References

  1. Woessner JF: Matrix metalloproteinases and their inhibitors in connective tissue remodeling.FASEB J 5:2145–2154, 1991.

    PubMed  CAS  Google Scholar 

  2. Grondahl-Hansen J, Christensen IJ, Rosenquist C,et al: High levels of Urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis.Cancer Res 53:2513–2521, 1993.

    PubMed  CAS  Google Scholar 

  3. Liotta LA, Stetler-Stevenson W: Metalloproteinases and cancer invasion.Semin Cancer Biol 1:99–106, 1990.

    PubMed  CAS  Google Scholar 

  4. Birkedal-Hansen H, Moore W, Bodden M,et al: Matrix-metalloproteinases: A review.Crit Rev Oral Biol Med 4:197–250, 1993.

    PubMed  CAS  Google Scholar 

  5. Davies B, Waxman J, Wasan H,et al: Levels of matrix metalloproteinases in bladder cancer correlate with tumor grade and invasion.Cancer Res 53:5365–5369, 1993.

    PubMed  CAS  Google Scholar 

  6. Davies B, Miles DW, Happerfield LC,et al: Activity of type IV collagenases in benign and malignant breast disease.Br J Cancer 67:1126–113, 1993.

    PubMed  CAS  Google Scholar 

  7. Iwata H, Kobayashi S, Iwase H,et al: Production of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Human Breast Carcinomas.Jpn J Cancer Res 87:602–611, 1996.

    PubMed  CAS  Google Scholar 

  8. Monteagudo C, Merino MJ, San-Juan J,et al: Immuno-histochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue.Am J Pathol 136:585–59, 1990.

    PubMed  CAS  Google Scholar 

  9. Poulsom R, Hanby AM, Pignatelli M,et al: Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin.J Clin Pathol 46:429–436, 1993.

    Article  PubMed  CAS  Google Scholar 

  10. Sato H, Takino T, Okada Y,et al: A matrix metalloproteinase expressed on the surface of invasive tumour cells.Nature 370:61–65, 1994.

    Article  PubMed  CAS  Google Scholar 

  11. Okada A, Bellocq JP, Rouyer N,et al: Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas.Proc Natl Acad Sci USA 92:2730–2734, 1995.

    Article  PubMed  CAS  Google Scholar 

  12. Polette M, Nawrocki B, Gilles C,et al: MT-MMP expression and localization in human lung and breast cancers.Virchows Arch 428:29–35, 1996.

    Article  PubMed  CAS  Google Scholar 

  13. Galis ZS, Sukhova GK, and Libby P: Microscopic localization of active proteinases by in situ zymography: detection of matrix metalloproteinase acticity in vascular tissue.FASEB J 9:974–980, 1995.

    PubMed  CAS  Google Scholar 

  14. Galis ZS, Sukhova GK, Lark MW,et al: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.J Clin Invest 94:2493–2503, 1994.

    Article  PubMed  CAS  Google Scholar 

  15. Pardo A, Selman M, Ridge K,et al: Increased expression of gelatinases and collagenase in rat lungs exposed to 100% oxygen.Am J Respir Crit Care Med 154:1067–1075, 1996.

    PubMed  CAS  Google Scholar 

  16. Kataoka M, Yamagata S, Akiyama S,et al: Matrix metalloproteinase 2 and 9 in esophageal cancer: correlation with organ metastasis.Int J Oncology 8:773–779, 1996.

    Google Scholar 

  17. Zucker S, Lysik RM, Zarrabi MH,et al: Mr 92, 000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer.Cancer Res 53:140–146, 1993.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Iwata, H., Yamamoto, M., Nemori, R. et al. Localization of gelatinolytic activity can be detected in Breast Cancer tissues by filmin situ zymography. Breast Cancer 8, 111–115 (2001). https://doi.org/10.1007/BF02967489

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02967489

Key words

Navigation